<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 05 Feb 2021 07:58:05 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Nat Biotech | CAR-T专利格局：澳门大学胡元佳团队利用专利大数据深入分析CAR-T全球研发生态</title><link>https://mp.weixin.qq.com/s/26SqApCV43QRy6sYWs1b1A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2h0Oo84dbLIrnd8pqLY17MghTugejEf82IGPkOaBEVLdI91ibNzt7Wqag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T专利布局至关重要]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>三款BiTE候选双抗停止临床研究！喜忧参半的安进2020财报丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/y52sKCHNPw3Z-dmwlTZHGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hJp8fNJe5rlYk9ib2F3ZKibHJMfKoibAbPLzyF32dxaLwKmxcv9Pdr8zbA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内双抗正蓬勃发展]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>祐和医药与君实生物合作数据亮眼，CD40联用PD-1大放异彩丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/8ivhF6OtCTuzkNn_qbyH1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hyhoewBACibSyYEwEYFzxIJmKQ2XgpoWTmKz051cnxaXNR51Aeib5JLXg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>联用策略发挥更好的治疗效果]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>治疗镰状细胞病，更安全的慢病毒基因疗法获欧盟优先药物称号，能够在低清髓预处理的情况下发挥作用丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/pxFPuo5Kun1iko6uSnClgA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIt8Y2RibubUOJmGSibJ3bTg2hSrp8MXxuibJxc6SkMycIyYPU4Pr32mWnaIltmP6wsJaibEuIwOOibbSMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>SCD基因疗法进展]]></content:encoded><pubDate>Thu, 04 Feb 2021 23:27:59 +0800</pubDate></item><item><title>在全球创新环境下，生物制药公司如何转型与突围丨峰客洞见</title><link>https://mp.weixin.qq.com/s/0YUJOLFAfrOSWgGa0asW3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPpX6ziaGpPSc1onvIfpicWagZ0SfVBCOzjWdoOs5BcUicSnUCqcKBY0miaQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>峰客访谈 · 洞见专栏]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>方达医药新增6200平方米实验室，扩张大分子生物分析和中心实验室业务，新建药物活性筛选生物实验室</title><link>https://mp.weixin.qq.com/s/r0Rn3SWMPmoQMCbZ1ldtYw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPyVSwIa510ticLorgkL8oS1FQp3KIyCc1jkrG4HOoYG7jC4Lib7aPTVAA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>预计2021年下半年投入使用]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>靶向CDH6！第一三共第6款Dxd ADC启动临床试验丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/dcJx7ty8GNHr_zGnZ7FGaQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPA1iacBqStt7icPS1miaTouYyq4ygicibu0WnfB8dpZa5dUfv3oOZLKTjtibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>first-in-class]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>药融资丨Krystal拟募集1亿美元，推进皮肤病基因疗法</title><link>https://mp.weixin.qq.com/s/BmA2_ZFYSV9SVEflVcPVyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6JjN8LEHo9E7P9gp1hpuW9OMNZaic7ZrlZ5vNdZr9QENN2KauoHkTbz2DHKemN67zUSlYLXOo6EDw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>专利基因治疗平台由工程HSV-1载体和皮肤优化基因转移技术组成。]]></content:encoded><pubDate>Wed, 03 Feb 2021 23:47:03 +0800</pubDate></item><item><title>探索政企合作创新之路，打造生物产业良性生态——丹纳赫生命科学联合火石创造、高瓴资本圆满举办第一届中国生物产业园区合作发展高峰论坛</title><link>https://mp.weixin.qq.com/s/xLsCTu_S64XhXUmhlFxMCA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPJmZTwmNqibHz39ILuSn30ODgSWVQMQyuxIGMcrtBxiaOm60AqNMjTaYQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>共话中国生物医药产业]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>重磅！陈新滋院士受聘为广东省细胞与基因治疗创新药物工程技术研究中心学术委员会主任及普瑞金科学委员会主席</title><link>https://mp.weixin.qq.com/s/6OFT1zbYDTMq_8C6FvW6FA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPia7prrsWllUyVdeegTu7IttBgRaFpzAW3p1f4ymeUZ6OX6tVEhZVKzw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>致力建成国际化的细胞与基因治疗创新药物卡脖子关键技术突破研发平台]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>罕见病迎来新的里程碑！Spark完成AAV基因治疗完成首例患者给药丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/iTVOb7zDBnCXFrMwvqsDLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6UAtI8niamvsL7HKy9Tw0GUmJ0mfZiaESicPQ1sOJ6Sfnp3b1IkoLDk2Ow/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>又一款肝靶向的AAV基因疗法]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>传奇生物BCMA CAR-T在欧盟的上市申请加速审评请求获批准，预计上半年递交丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/MK_yXx6St7coMmcyXyQJYg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6KWWOannCz17fzaKmVGnA27SPdtx0Grl3QDNHicebbZoHMJRqibiavHiczw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内外BCMA靶点竞争格局]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>药融资丨国产PD-1出海记：11.1亿美元，君实PD-1单抗License out！</title><link>https://mp.weixin.qq.com/s/cNsqjsuu5t7Vv8Myqlrm2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6jPwiasBesoibtSjGNZh0XGM6mxRKSUaRYkw6XPuC5iar1BVFwia8zc6Lgg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内4款PD-1单抗全部出海]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>国家药监局2021年监管计划及2020年年度总结！</title><link>https://mp.weixin.qq.com/s/iPjYjKBOSdv7CeIDQILPgQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsqddepUaYgLuDucwrRlGyPQCibJjuDV63NfhzxBwiaicqj8eOwatGlkHkUQOQQVlvmzwPTlAMTUAyBQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国家药监局2021年监管计划及2020年的监管总结]]></content:encoded><pubDate>Wed, 03 Feb 2021 16:11:35 +0800</pubDate></item><item><title>细胞转染和血清，恩怨情仇你可了解？</title><link>https://mp.weixin.qq.com/s/QFaObGB4uZTGs2M5G_Dk3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6mtPah8mkU6amjtBib663YyZRl6Viammw3rWPicBR2hHE8uA5gPmc6c5BA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>血清和转染试剂对于转染实验非常重要]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:32:31 +0800</pubDate></item><item><title>迎利好：中国医学科学院血液病医院牵头推动CAR-T等规范化进程；细胞免疫国家队呼之欲出</title><link>https://mp.weixin.qq.com/s/NZSOsMBDVWY3MKa0LKUQig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6RJKkCRAcjL2H5hJAPHeex75nFVDjJOHJhRNFk4GmicJETEXK5m8g2Yg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>火热的CAR-T]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:32:31 +0800</pubDate></item><item><title>药融资丨时隔5个月，嘉因生物再次完成数千万美元B+轮融资</title><link>https://mp.weixin.qq.com/s/T2oU8R3oprtssXPLmx0HDQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj6M85P4M13QJqcfZB7SibIib17d78TvibEGCW1nBW8vkia1rFddPLxajjKsg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>中国创新基因疗法公司]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:32:31 +0800</pubDate></item><item><title>针对β-地贫和镰状细胞病，新型慢病毒载体显著提高基因治疗的安全性和有效性丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/bzSXYCKb8ZJFHMLj6rMyQA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItzbyKDHlHfIw26hj8zPvj69hZHGMmicLDjtLB6PnbQtVtmHibb5mErf9quA6XOoibicvzqf0BRFq6TNg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>临床前数据显示优于常用的病毒载体]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:32:31 +0800</pubDate></item><item><title>国内CAR-T市场正式开启商业化，整个产业链如何赋能其顺利推进丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/D66jHJnb7FhQgaxfPp7N0A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsdMuQPGZs1BFmCCIjnZpECGo2OEozmG3egjRYWDFyiaxpGnTT6XCO786jUrkz98nfqfia2blCbQr1w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>先聊聊供给产能！]]></content:encoded><pubDate>Sun, 31 Jan 2021 22:38:50 +0800</pubDate></item><item><title>好消息！除了英国变异株，这款新冠疫苗应对南非新冠变异毒株也有效丨医麦新观察</title><link>https://mp.weixin.qq.com/s/iK1xxCYFvNwG9TuYpInhnA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItW5JicqvBcOE3t5zU4NaWtiaWA4dCkQYCaAV24MHoynm5RVKIickwG1RibfyTUQyfNodn8TWdVbBl8vw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>疫苗依然抗疫的关键！]]></content:encoded><pubDate>Sun, 31 Jan 2021 22:38:50 +0800</pubDate></item></channel></rss>